Consequently, PACAP has been proposed as a promising therapeutic target for stress-associated disorders, including anxiety, post-traumatic stress disorder, and depression, through its modulation of the HPA axis, autonomic function, and emotional neural circuits [10, 13, 14]. Here, ADCYAP1 is linked to depressive symptom measurement.